Libre, in collaboration with Nomura's Laser Digital, is bringing institutional investment funds on-chain via the Injective blockchain, representing a significant step in real-world asset tokenization and bridging traditional finance with DeFi.
Institutional Tokenization of Private Funds
The partnership between Libre and Injective allows institutional and accredited investors to seamlessly access some of the world's largest financial firms through blockchain. Key funds now available through this integration include: Laser Carry Fund (LCF) by Laser Digital, optimized for returns through funding rates and staking yields; BlackRock Money Market Fund, providing stable, low-risk yields; and Hamilton Lane SCOPE Senior Credit Fund, offering access to institutional-grade fixed-income products.
How Libre's Tokenization Framework Works
Libre's RWA tokenization transforms traditional financial instruments into blockchain-based tokens, improving liquidity, transparency, and efficiency. The process involves converting assets into digital tokens via smart contracts, fractional ownership, regulated access for institutions, and integration with DeFi for collateral use or trading. Portfolio managers can program dynamic asset allocation rules, simplifying processes and reducing costs.
Why Injective? A Blockchain Built for Institutional Finance
Injective is becoming increasingly popular with institutional investors due to its high-performance infrastructure, which includes an advanced decentralized order book, fast finality, and low fees, making it ideal for high-value financial transactions. It supports the use of tokenized assets as collateral and ensures compliance with regulatory standards.
The integration of Libre and Laser Digital on the Injective platform opens new opportunities for investors, simplifies access to high-end finance, and accelerates the mass adoption of DeFi in the institutional environment.
